A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...
A study led by the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong ...
After nonfatal myocardial infarction or stroke, initiation of a GLP-1 receptor agonist was linked to reduced risk for all-cause and CV-related mortality in patients with diabetes, researchers reported ...
“High-sensitivity CRP has been shown to be an independent marker of risk in addition to and in some cases over and above all ...